Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,165 | 74,148 | 9,443 | 13,148 | 7,846 |
| Marketable Securities | 91,025 | 27,549 | 1,503 | 66,870 | 64,728 |
| Receivables | 5,154 | 42,222 | 96 | 12,786 | 11,875 |
| Inventories | N/A | N/A | N/A | 2,391 | 4,148 |
| Other current assets | 0 | 0 | 0 | 3,505 | 274 |
| TOTAL | $121,840 | $146,099 | $12,535 | $100,448 | $90,181 |
| Non-Current Assets | |||||
| PPE Net | 5,985 | 6,540 | 9,900 | 7,096 | 8,408 |
| Intangibles | 0 | 0 | 0 | 1,891 | 2,621 |
| Other Non-Current Assets | 1,900 | 2,009 | 2,016 | 6,208 | 7,975 |
| TOTAL | $7,885 | $8,549 | $11,916 | $15,194 | $19,004 |
| Total Assets | $129,725 | $154,648 | $24,451 | $115,643 | $109,184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,363 | 3,718 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,097 | 1,188 | 659 | 2,640 | 2,372 |
| Accrued Expenses | 8,520 | 8,533 | 4,663 | 2,590 | 4,161 |
| TOTAL | $24,743 | $24,834 | $10,068 | $7,081 | $10,839 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,750 | 13,750 | 1,028 | 885 | 4,306 |
| Other Non-Current Liabilities | 2,777 | 2,223 | 2,168 | 0 | 0 |
| TOTAL | $53,839 | $67,389 | $4,209 | $155 | $98 |
| Total Liabilities | $78,582 | $92,223 | $14,277 | $7,236 | $10,937 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,737 | 19,593 | 6,609 | 6,531 | 6,160 |
| Common Shares | 20 | 20 | 3 | 26 | 25 |
| Retained earnings | -172,546 | -155,305 | -126,857 | -99,729 | -103,631 |
| Other shareholders' equity | 203 | -400 | -38 | 1,305 | 1,168 |
| TOTAL | $51,143 | $62,425 | $10,174 | $108,407 | $98,247 |
| Total Liabilities And Equity | $129,725 | $154,648 | $24,451 | $115,643 | $109,184 |